Immunogenetics, resistance, and susceptibility to theiler's virus infection

Experimental Models of Multiple Sclerosis

Volumn , Issue , 2005, Pages 629-644

  Melvold, Roger W ^a,b   Miller, Stephen D ^a,b  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

demyelinating disease; genetics; H2; H2 D; major histocompatibility complex (MHC); multiple sclerosis; Theiler's murine encephalomyelitis virus (TMEV)

Indexed keywords

EID: 84884432920     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-25518-4_31     Document Type: Chapter

References (96)

1. Olson, J.K., Croxford, J.L. and Miller, S.D. 2001. Virus-induced autoImmunity: Potential role of viruses in initiation, perpetuation, and progression of T cell-mediated autoImmune diseases. Viral Immunol. 14:227-250.
2. Kurtzke, J.F. 1993. Epidemiologic evidence for multiple sclerosis as an infection. Clin. Microbiol. Rev. 6:382-427.
3. Compston, A and Sawyer, S. 2002. Genetic analysis of multiple sclerosis. Curr. Neurol. Neurosci. Rep. 2:259-266.
4. Kantarci, O.H., de Andrade, M. and Weinshenker, B.G. 2002. Identifying disease modifying genes in multiple sclerosis. J. NeuroImmunol. 123:144-159.
5. Sandovick, S. 2002. The genetics of multiple sclerosis. Clin. Neurol. Neurosurg. 104:199-202.
6. Fukazawa, T., Sasaki, H., Kikuchi, S., Hamada, T. and Tashiro, K. 2000. Genetics of multiple sclerosis. Biomed. Pharmacother. 54:103-106.
7. Oksenberg, J.R. and Barcellos, L.F.: 2000. The complex genetic aetiology of multiple sclerosis.
8. Compston, A. 2000. The genetics of multiple sclerosis. Clin. Chem. Lab. Med. 38:133-135.
9. Willer, C.J. and Ebers, G.C. 2000. Susceptibility to multiple sclerosis: Interplay between genes and environment. Curr. Opin. Neurol. 13:241-147.
10. Lipton, H.L. and M.C. Dal Canto. 1979. Susceptibility of inbred mice to encephalomyelitis virus. Infect. Immun. 26 : 369-374.
11. Lipton, H.L., Miller, S.D., Melvold, R.W. and Fujinami, R.S. 1986. "Theiler's murine encephalomyelitis virus (TMEV) infection in mice as a model for multiple sclerosis." In Concepts in Viral Pathogenesis II, A.L. Notkins and M.B.A. Oldstone, eds., pp. 248 - 254, Springer-Verlag, New York.
12. Rodriguez, M., Pease, L.R. and C.S. David. 1986. Immune-mediated injury of virusinfected oligodendrocytes. A model of multiple sclerosis. Immunology Today 7:359- 366.
13. Blankenhom, E.P. and Stranford, S.A. 1992. Genetic factors in demyelinating disease: genes that control demyelination due to experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus. Regional Immunol. 4 : 331-343.
14. Miller, S.D., Karpus, W.J., Pope, J.G., Dal Canto, M.C. and Melvold, R.W. 1994. "Theiler's murine encephalomyelitis virus-induced demyelinating disease." In: Animal Models for AutoImmune Diseases, I.R. Cohen, ed., pp. 23-38, Academic Press, New York.
15. Oleszak, E.L., Kuzmak, J., Good, R.A. and Platsoucas, C.D. 1995. Immunology of Theiler's murine encephalomyelitis virus infection. Immunol. Res. 14 : 13-33.
16. Dal Canto, M.C., Kim, B.S., Miller, S.D. and Melvold, R.W. 1996. Theiler's Murine Encephalomyelitis Virus (TMEV)-induced demyelination: A model for human multiple sclerosis. Methods 10:453-461.
17. Monteyne, P., Bureau, J.F. and Brahic, M. 1997. The infection of mouse by Theiler's virus: from genetics to Immunology, Immunol. Rev. 159:163-176.
18. Brahic, M. and Bureau, J.F. 1998. Genetics of susceptibility to Theiler's virus infection. BioEssays 20:627-633.
19. Pevear, D.C., Calenoff, M., Rozhon, E. and Lipton, H.L. 1987. Analysis of the complete nucleotide sequence of the picornavirus Theiler's virus indicates that it is closely related to cardioviruses. J. Virol. 61:1507-1516.
20. Lipton, H.L. 1975. Theiler's virus infection in mice: An unusual biphasic disease process leading to demyelination. Infect. Immun. 11:1147-1155.
21. Miller, S.D. and Gerety, S.J. 1990. Immunologic aspects of Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. Semin. Virol. 1:263- 272.
22. Karpus, W.J., Pope, J.G., Peterson, J.D., Dal Canto, M.C. and Miller, S.D. 1995. Inhibition of Theiler's virus-mediated demyelination by peripheral Immune tolerance induction. J. Immunol. 155:947-957.
23. Miller, S.D., Vanderlugt, C.L., Begolka, W.S., Pan, W., Yauch, R.L., Neville, K.L., Katz-Levy, Y., Carrizosa, A. and Kim, B.S. 1997. Persistent infection with Theiler's virus leads to CNS autoImmunity via epitope spreading. Nature Med. 3:1133-1136.
24. Begolka, W.S., Vanderlugt, C.L., Rahbe, S.M. and Miller, S.D. 1998. Differential expression of inflammatory cytokines parallels progression of CNS pathology in two clinically distinct models of multiple sclerosis. J. Immunol. 161:4437-4446.
25. Haines, J.L., Ter-Minassian, M., Bazyk, A. et al (26 additional authors). 1996. A complete genomic screening for multiple sclerosis underscores a role for the major histocompatibility complex. Nature Genetics 13:469-471.
26. Liblau, R. and Gautam, A.M. 2000. HLA, molecular mimicry and multiple sclerosis. Rev. Immunogenet. 2:95-104.
27. Kuokkanen, S., Sundvall, M., Terwilliger, J.D., Tienari, P.J., Wikstrom, J., Holmdahl, R., Petterson, U. and Pelronen, L. 1996. A putative vulnerability locus to multiple sclerosis maps to 5p14 - p12 in a region syntenic to the murine locus Eae2. Nature Genetics 13:477-480.
28. Nicholson, S., Peterson, J.D., Miller, S.D., Dal Canto, M.C. and Melvold, R.W. 1994. BALB/c substrain variation in susceptibility to Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. J. NeuroImmunol. 52:19-24.
29. Simas, J.P. and J.K. Fazakerley. 1996. The course of disease and persistence of virus in the central nervous system varies between individual CBA mice infected with the BeAn strain of Theiler's murine encephalomyelitis virus. J. Gen. Virol. 77:2701-2711.
30. Clatch, R.J., Lipton, H.L. and Miller, S.D. 1987. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. II. Survey of host Immune responses and central nervous system virus titers in inbred mouse strains. Microbial Pathogenesis 3:327-337.
31. Patick, A.K., Pease, L.R., David, C.S. and Rodriguez, M. 1990. Major histocompatibility complex-conferred resistance to Theiler's virus-induced demyelinating disease is inherited as a dominant trait in B10 congenic mice. J. Virol. 64:5570-5576.
32. Olsberg, C.A., A. Pelka, T.M. Creighton, S.D. Miller, C.R. Waltenbaugh, M.C. Dal Canto, H.L. Lipton and R.W. Melvold. 1993. Induction of Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in genetically resistant mice. Regional Immunol. 5 : 1-10.25.
33. Pelka, A.E., Olsberg, C.A., Miller, S.D., Waltenbaugh, C.R., Dal Canto, M.C. and Melvold, R.W. 1993. Effects of irradiation on resistance to Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. Cell. Immunol. 152:440-455.
34. Teuscher, C., Rhein, D.M., Livingstone, K.D., Paynter, R.A., Doerge, R.W., Nicholson, S.M. and Melvold, R.W. 1997. Evidence that Tmevd2 and eae3 may represent either a common locus or members of a gene complex controlling susceptibility to Immunologically mediated demyelination in mice. J. Immunol. 159:4930-4934.
35. Nicholson, S.M., Jokinen, D.M., Dal Canto, MC., Kim, B.S. and Melvold, R.W. 1995. Genetic analysis of susceptibility of the SWR strain to TMEV-induced demyelinating disease. J. NeuroImmunol. 59:19-28.
36. Lando, Z., Teitelbaum, D. and Arnon, R. 1980. Induction of experimental allergic encephalomyelitis in genetically resistant strains of mice. Nature 287:551-552.
37. Kappel, C.A., Melvold, R.W. and Kim, B.S. 1990. Influence of sex on susceptibility in the Theiler's murine encephalomyelitis virus model for multiple sclerosis. J. NeuroImmunol. 29:15-19.
38. Melvold, R.W., Jokinen, D.M, Knobler, R.L. and Lipton, H.L. 1987. Variations in genetic control of susceptibility to Theiler's murine encephalomyelitis virus (TMEV)- induced demyelinating disease. I. Differences between susceptible SJL/J and resistant BALB/c strains map near the T cell beta chain constant gene on chromosome 6. J. Immunol. 138:1429-1433.
39. Knobler, R.L., Lublin, M.D., Linthicum, D.S., Cohn, M, Melvold, R., Lipton, H.L., Taylor, B.S. and Beaner, W.G. 1988. Genetic regulation of susceptibility and severity of demyelination. Ann. N.Y. Acad. Sci. 540:735-737.
40. Lipton, H.L. and Melvold, W. 1984. Genetic analysis of susceptibility to Theiler's virus-induced demyelinating disease in mice. J. Immunol. 132 : 1821-1825.
41. Dal Canto, M.C., Melvold, R.W. and Kim, B.S. 1995. A hybrid between a resistant and a susceptible strain of mouse alters the pattern of Theiler's murine encephalomyelitis virus-induced white matter disease and favors oligodendrocyte-mediated remyelination. Mult. Scler. 1:95-103.
42. Melvold, R.W., Jokinen, D.M, Miller, S.D., Dal Canto, M.C. and Lipton, H.L. 1987. "H-2 genes in TMEV-induced demyelination, a model for multiple sclerosis." In Major Histocompatibility Genes and Their Role in Immune Function, C. David, ed., pp. 735- 745, Plenum, New York.
43. Miller, S.D., Clatch, R.J. and Lipton, H.L. 1988. Fine specificity of T-cell-mediated Immune responses of susceptible and resistant strains in Theiler's murine encephalomyelitis virus-induced demyelinating disease.
44. Rodriguez, M., David, C.S. and Pease, L.R. 1987. "The contribution of the MHC gene products to demyelination by Theiler's virus." In Major Histocompatibility Genes and Their Role in Immune Function. C. David, ed., pp. 747-756, Plenum, New York.
45. Rodriguez, M. and David, C.S. 1985. Demyelination induced by Theiler's virus: Influence of the H-2 haplotype. J. Immunol. 135:2145-2148.
46. Clatch, R.J., Melvold, R.W., Dal Canto, M.C., Miller, S.D. and Lipton, H.L. 1987. The Theiler's murine encephalomyelitis virus (TMEV) model for multiple sclerosis shows a strong influence of the murine equivalents of HLA-A, B and C. J. NeuroImmunol. 15:121-135.
47. Kappel, C.A., Dal Canto, M.C., Melvold, R.W. and Kim, B.S. 1991. Hierarchy of effects of the major histocompatibility complex and T cell receptor β-chain genes in susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Immunol. 147 4322-4326.
48. Clatch, R.J., Melvold, R.W., Miller, S.D. and Lipton, H.L. 1985. Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TMEV-specific delayed type hypersensitivity. J. Immunol. 135:1408-1414.
49. Rodriguez, M., Leibowitz, J. and David, C.S. 1986. Susceptibility to Theiler's virusinduced demyelination. Mapping of the gene within the H-2D region. J. Exp. Med. 163:620-631.
50. Azoulay-Cayla, A., Syan, S., Brahic, M. and Bureau, J.F. 2001. Roles of the H-2D(b) and H-K(b) genes in resistance to persistent Theiler's murine encephalomyelitis virus infection of the central nervous system. J. Gen. Virol. 82:1043-1047.
51. b mice deficient in beta 2-microglobulin. J. Immunol. 151 : 266-278.
52. Fiette, L., Aubert, C., Brahic, M. and Pena Rossi, C. 1993. Theiler's virus infection of β2-microglobulin-deficient mice. J. Virol. 67:589-592.
53. Pullen, L.C., Miller, S.D., Dal Canto, M.C. and Kim, B.S. 1993. Class-I deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination. Eur. J. Immunol. 23:2287-2293.
54. Begolka, W.S., Haynes, L.M., Olson, J.K., Padilla, J., Neville, K.L., Dal Canto, M, Palma, J., Kim, B.S. and Miller, S.D. 2001. CD8-deficient SJL mice display enhanced susceptibility to Theiler's virus infection and increased demyelinating pathology. J. Neurovirol. 7:409-420.
55. Lipton, H.L., Melvold, R., Miller, S.D. and Dal Canto, M.C. 1995. Mutation of a major histocompatibility class 1 locus, H-2D, leads to an increased virus burden and disease susceptibility in Theiler's virus-induced demyelinating disease. J. Neurovirol. 1:138- 144.
56. b gene become resistant to persistent infection by Theiler's virus. J. Virol. 68:4049-4052.
57. Rodriguez, M. and David, C.S. 1995. H-2D a transgene suppresses Theiler's virusinduced demyelination in susceptible strains of mice. J. Neurovirol. 1 : 111-117.
58. Lin, X., Pease, L.R. and Rodriguez, M. 1997. Differential generation of class I H-2Dversus H-2K-restricted cytotoxicity against a demyelinating virus following central nervous system infection. Eur. J. Immunol. 27:963-970.
59. b molecules complexed with a viral VP2 peptide lacking a consensus anchor residue. J. Virol. 71:5244 - 5250.
60. Dethlefs, S., Escriou, N., Brahic, M., Van der Werf, S. and Larsson-Sciard, E. 1997. Theiler's virus and Mengo virus induce cross-reactive cytotoxic T lymphocytes restricted to the same Immunodeterminant VP2 epitope in C57BL/6 mice. J. Virol. 71:5361-5365.
61. Azoulay-Cayla, A., Dethlefs, S., Perarnau, B., Larsson-Sciard, E.L., Lemonnier, F.A., Brahic, M. and Bureau, J.F. 2000. H-2D(b-/-) mice are susceptible to persistent infection by Theiler's virus. J. Virol. 74:5470-5476.
62. Taneja, V. and David, C.S. 1999. HLA class II transgenic mice as models of human diseases. Imm. Rev. 169:67-69.
63. Rodriguez, M., Pedrinaci, S. and David, C. 1993. Human class 1 major histocompatibility complex transgene prevents virus-induced demyelination in susceptible mutant B10.D2dml mice. Ann. Neurol. 33:208-212.
64. Pavelko, K.D., Drescher, K.M., McGavern, D.B., David, C.S. and Rodriguez, M. 2000. HLA-DQ polymorphism influences progression of demyelination and neurologic deficits in a viral model of multiple sclerosis. Mol. Cell. Neurosci. 15:495-509.
65. Melvold, R.W., Jokinen, D.M., Miller, S.D., Dal Canto, M.C. and Lipton, H.L. 1990. Identification of a locus on mouse chromosome 3 involved in differential susceptibility to Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. J. Virol. 64:686-690.
66. Bureau, J.F., Drescher, K.M., Pease, L.R., Vikoren, T., Delcroix, M., Zoecklein, L., Brahic, M. and Rodriguez, M. 1998. Chromosome 14 contains determinants that regulate susceptibility to Theiler's virus-induced demyelination in the mouse. Genetics 148: 1941-1949.
67. Aubagnac, S., Brahic, M. and Bureau, J.F. 1999. Viral load and a locus on chromosome 11 affect the late clinical disease caused by Theiler's virus. J. Virol. 73:7965-7971.
68. Aubagnac, S, Brahic, M. and Bureau, J.F. 2001. Viral load increases in SJL/J mice persistently infected by Theiler's virus after inactivation of the beta(2)m gene. J. Virol. 75:7723-7726.
69. Bureau, J.F., Montagutelli, X., Lefebre, S., Guenet, J-L., Pla, M. and Brahic, M. 1992. The interaction of two groups of murine genes determines the persistence of Theiler's virus in the central nervous system. J. Virol. 66:4698-4704.
70. Bureau, J.F., Montagutelli, X., Bihl, F., Lefebvre, S., Guenet, J.L. and Brahic, M. 1993. Mapping loci influencing the persistence of Theiler's virus in the murine central nervous system. Nat. Genet. 5:87-91.
71. Bihl, F., Brahic, M. and Bureau, J.F. 1999. Two loci, Tmevp2 and Tmevp3, located on the telomeric region of chromosome 10, control the persistence of Theiler's virus in the central nervous system of mice. Genetics 152:385-392.
72. Aubagnac, S., Brahic, M. and Bureau, J.F. 2002. Bone marrow chimeras reveal non-H- 2 hematopoietic control of susceptibility to Theiler's virus persistent infection. J. Virol. 76:5807-5812.
73. Vigneau, S., Levillayer, F., Crespeau, H., Cattolico, L., Caudron, B., Bihl, F., Robert, C., Brahic, M., Weissenbach, J. and Bureau, J.F. 2001. Homology between a 173-kb region from mouse chromosome 10, telomeric to the Ifng locus, and human chromosome 12q15. Genomics 78:206-213.
74. Butterfield, R.J., Roper, R.J., Rhein, D.M., Melvold, R.W., Haynes, L., Ma, R.Z., Doerge, R.W. and Teuscher, C. Sex-specific QTL govern susceptibility to Theiler's murine encephalomyelitis virus-induced demyelination (TMEVD). Genetics (in press).
75. Rodriguez, M., Patick, A.K, Pease, L.R. and David, C.S. 1992. Role of T cell receptor V beta genes in Theiler's virus-induced demyelination of mice. J. Immunol. 148 921- 927.
76. Rodriguez, M., Nabozny, G.H., Thiemann, R.L. and David, C.S. 1994. Influence of deletion of T cell receptor V beta genes on the Theiler's virus model of multiple sclerosis. AutoImmunity 19:221-230.
77. Bahk, Y.Y., Kappel, C.A., Rasmussen, G. and Kim, B.S. 1997. Association between susceptibility to Theiler's virus-induced demyelination and T-cell receptor Jbetal-Cbetal polymorphism rather that Vbeta deletion. J. Virol. 71:4181-4185.
78. Beall, S.S, Concannon, P., Charmley, P., McFarland, H.F., Gatti, R.A., Hood, L.E., McFarlin, D.E. and Biddison, W.E. 1989. The germline repertoire of T cell receptor β- chain genes in patients with chronic progressive multiple sclerosis. J. NeuroImmunol. 21:59-66.
79. Oksenberg, J.R., M. Sherritt, A.B. Begovich, H.A. Erlich, C.C. Bernard, L.L. Cavalli-Sforza and L. Steinman. 1989. T-cell receptor Vα and Cα alleles associated with multiple sclerosis and myasthenia gravis. Proc. Natl. Acad. Sci. USA 86:988-992.
80. Seboun, E., Robinson, M.A., Doolittle, T.H., Clulla, T.A., Kindt, T.J. and Hauser, S.L. 1989. A susceptibility locus for multiple sclerosis is linked to the T cell receptor β chain complex. Cell 57:1095-1100.
81. Hashimoto, L.L., Mak, T.W. and Ebers, G.C. 1992. T-cell alpha chain polymorphisms in multiple sclerosis. J. NeuroImmunol. 40:41-48.
82. Bihl, F., Pena-Rossi, C., Guenet, J.L., Brahic, M. and Bureau, J.F. 1997. The shiverer mutation affects the persistence of Theiler's virus in the central nervous system. J. Virol. 71:5025-5030.
83. Hertzler, S., Kallio, P. and Lipton, H.L 2001. UDP-galactose transporter is required for Theiler's virus entry into mammalian cells. Virology 286:336-344.
84. Rodriguez, M., Patick, A.K. and Pease, L.R. 1990. Abrogation of resistance to Theiler's virus-induced demyelination in C57BL mice by total body irradiation. J. NeuroImmunol. 26:189-199.
85. Nicholson, S.M., Dal Canto, M.C., Miller, S.D. and Melvold, R.W. 1996. Adoptively transferred CD8 + T lymphocytes provide protection against TMEV-induced demyelinating disease in BALB/c mice. J. Immunol. 156:1276-1283.
86. Haynes, L.M., Vanderlugt, C.L., Dal Canto, M.C., Melvold, R.W. and Miller, S.D. 2000. CD8+ T cells from Theiler's virus-resistant BALB/cByJ mice downregulate pathogenic virus-specific CD4 + T cells. J.NeuroImmunol. 106:43-52.
87. Pullen, LC., Park, S.H., Miller, S.D., Dal Canto, M.C. and Kim, B.S. 1995. Treatment with bacterial LPS renders genetically resistant C57BL/6 mice susceptible to Theiler's virus-induced demyelinating disease. J. Immunol. 155:4497-1503.
88. Karls, K.A., Denton, P.W. and Melvold, R.W. 2002. Susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease in BALB/cAnNCr mice is related to absence of a CD4 + T-cell subset. Mult. Scler. 8:469-474.
89. Lando, Z., Teitelbaum, D. and Arnon, R. 1979. Effect of cyclophosphamide on suppressor cell activity in mice unresponsive to EAE. J. Immunol. 123:2156-2160.
90. Fiette, L., Aubert, C., Brahic, M. and Pena Rossi, C. 1996. Infection of class IIdeficient mice by the DA strain of Theiler's virus. J. V irol. 70:4811-4815.
91. Njenga, M.K., Pavelko, K.D., Baisch, J., Lin, S., David, C., Leibowitz, J. and Rodriguez, M. 1996. Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice. J. Virol: 70:1729-1737.
92. Fiette, L., Aubert, C., Muller, U., Aguet, M., Brahic, M. and Bureau, J.F. 1995. Theiler's virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptors. J. Exp. Med. 181:2069-2076.
93. Rodriguez, M., Roos, R.P., McGavern, D., Zoecklein, L., Pavelko, K., Sang, H. and Lin, X. 2000. The CD4-mediated Immune response is critical in determining the outcome of infection using Theiler's viruses with VP1 capsid protein point mutations. Virol. 275:9-19.
94. Zhang, X., Brewer, L., Walcheck, B., Johnson, A., Pease, L.R. and Njenga, M.K. 2001. Theiler's virus-infected L-selectin-deficient mice have decreased infiltration of CD8(+) T lymphocytes in central nervous system but clear the virus. J. NeuroImmunol. 116:178-187.
95. Palma, J.P., Lee, H.G., Mohindru, M., Kang, B.S., Dal Canto, M., Miller, S.D. and Kim, B.S. 2001. Enhanced susceptibility to Theiler's virus-induced demyelinating disease in perforin-deficient mice. J. NeuroImmunol. 116:125-135.
96. Rossi, C., McAllister, A., Tanguy, M., Kagi, D. and Brahic, M. 1998. Theiler's virus infection of perforin-deficient mice. J. Virol. 72:4515-4519.